http://dbpedia.org/ontology/abstract
|
KM-233 is a synthetic cannabinoid drug whi … KM-233 is a synthetic cannabinoid drug which is a structural analog of Δ8-tetrahydrocannabinol (THC), the less active but more stable isomer of the active component of Cannabis. KM-233 differs from Δ8-THC by the pentyl side chain being replaced by a 1,1-dimethylbenzyl group. It has high binding affinity in vitro for both the CB1 and CB2 receptors, with a CB2 affinity of 0.91 nM and 13-fold selectivity over the CB1 receptor. In animal studies, it has been found to be a potential treatment for glioma, a form of brain tumor. Many related analogues are known where the 1,1-dimethylbenzyl group is substituted or replaced by other groups, with a fairly well established structure-activity relationship.tablished structure-activity relationship.
|
http://dbpedia.org/ontology/casNumber
|
628263-22-9
|
http://dbpedia.org/ontology/chEMBL
|
119592
|
http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/KM-233_Structure.svg?width=300 +
|
http://dbpedia.org/ontology/wikiPageID
|
36033185
|
http://dbpedia.org/ontology/wikiPageLength
|
4978
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1082424344
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Synthetic_cannabinoid +
, http://dbpedia.org/resource/Side_chain +
, http://dbpedia.org/resource/AMG-36 +
, http://dbpedia.org/resource/Cannabinoid_receptor_2 +
, http://dbpedia.org/resource/Structure-activity_relationship +
, http://dbpedia.org/resource/Cannabis_%28drug%29 +
, http://dbpedia.org/resource/Cannabinoid_receptor_1 +
, http://dbpedia.org/resource/Isomer +
, http://dbpedia.org/resource/Category:Benzochromenes +
, http://dbpedia.org/resource/Structural_analog +
, http://dbpedia.org/resource/Tetrahydrocannabinol +
, http://dbpedia.org/resource/AM-411 +
, http://dbpedia.org/resource/Glioma +
, http://dbpedia.org/resource/Pentyl +
, http://dbpedia.org/resource/Category:Cannabinoids +
, http://dbpedia.org/resource/Category:Phenols +
|
http://dbpedia.org/property/atcPrefix
|
none
|
http://dbpedia.org/property/c
|
25
|
http://dbpedia.org/property/casNumber
|
628263
|
http://dbpedia.org/property/chembl
|
119592
|
http://dbpedia.org/property/chemspiderid
|
8423597
|
http://dbpedia.org/property/h
|
30
|
http://dbpedia.org/property/iupacName
|
--Tetrahydro-6,6,9-trimethyl-3--6H-dibenzo[b,d]pyran-1-ol
|
http://dbpedia.org/property/o
|
2
|
http://dbpedia.org/property/smiles
|
CC1=CC[C@@H]2[C@@H]C3=CO
|
http://dbpedia.org/property/stdinchi
|
1
|
http://dbpedia.org/property/stdinchikey
|
GZYXCXRHVALIJD-WOJBJXKFSA-N
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Cannabinoid-stub +
, http://dbpedia.org/resource/Template:Cannabinoids +
, http://dbpedia.org/resource/Template:Reflist +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Benzochromenes +
, http://dbpedia.org/resource/Category:Cannabinoids +
, http://dbpedia.org/resource/Category:Phenols +
|
http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Drug +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/KM-233?oldid=1082424344&ns=0 +
|
http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/KM-233_Structure.svg +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/KM-233 +
|
owl:sameAs |
http://www.wikidata.org/entity/Q6333245 +
, http://sh.dbpedia.org/resource/KM-233 +
, http://dbpedia.org/resource/KM-233 +
, http://rdf.freebase.com/ns/m.0j_2ccb +
, https://global.dbpedia.org/id/4pGH2 +
, http://sr.dbpedia.org/resource/KM-233 +
, http://yago-knowledge.org/resource/KM-233 +
|
rdf:type |
http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/class/yago/Material114580897 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/WikicatPhenols +
, http://dbpedia.org/class/yago/Phenol114989545 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/class/yago/Part113809207 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://www.wikidata.org/entity/Q8386 +
|
rdfs:comment |
KM-233 is a synthetic cannabinoid drug whi … KM-233 is a synthetic cannabinoid drug which is a structural analog of Δ8-tetrahydrocannabinol (THC), the less active but more stable isomer of the active component of Cannabis. KM-233 differs from Δ8-THC by the pentyl side chain being replaced by a 1,1-dimethylbenzyl group. It has high binding affinity in vitro for both the CB1 and CB2 receptors, with a CB2 affinity of 0.91 nM and 13-fold selectivity over the CB1 receptor. In animal studies, it has been found to be a potential treatment for glioma, a form of brain tumor. Many related analogues are known where the 1,1-dimethylbenzyl group is substituted or replaced by other groups, with a fairly well established structure-activity relationship.tablished structure-activity relationship.
|
rdfs:label |
KM-233
|